Sonic Healthcare Ltd - Asset Resilience Ratio

Latest as of June 2008: 0.13%

Sonic Healthcare Ltd (SHL) has an Asset Resilience Ratio of 0.13% as of June 2008. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Sonic Healthcare Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Liquid Assets

AU$4.71 Million
≈ $3.33 Million USD Cash + Short-term Investments

Total Assets

AU$3.63 Billion
≈ $2.57 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (1994–2017)

This chart shows how Sonic Healthcare Ltd's Asset Resilience Ratio has changed over time. See Sonic Healthcare Ltd balance sheet independence to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Sonic Healthcare Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Sonic Healthcare Ltd (SHL) market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$0.00 0%
Short-term Investments AU$4.71 Million 0.13%
Total Liquid Assets AU$4.71 Million 0.13%

Asset Resilience Insights

  • Limited Liquidity: Sonic Healthcare Ltd maintains only 0.13% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Sonic Healthcare Ltd Industry Peers by Asset Resilience Ratio

Compare Sonic Healthcare Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Fleury S.A.
SA:FLRY3
Diagnostics & Research 16.06%
Wuhan Thalys Med Tech Co Ltd
SHG:603716
Diagnostics & Research 0.12%
Spectral Med Inc
TO:EDT
Diagnostics & Research 11.67%
Bcal Diagnostics Ltd
AU:BDX
Diagnostics & Research 0.00%
Genetic Signatures Ltd
AU:GSS
Diagnostics & Research 60.91%
Australian Clinical Labs Ltd
AU:ACL
Diagnostics & Research 4.11%
Monash Ivf Group Ltd
AU:MVF
Diagnostics & Research 1.60%
Healius Ltd
AU:HLS
Diagnostics & Research 0.06%

Annual Asset Resilience Ratio for Sonic Healthcare Ltd (1994–2017)

The table below shows the annual Asset Resilience Ratio data for Sonic Healthcare Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2017-06-30 0.00% AU$0.00
≈ $0.00
AU$7.88 Billion
≈ $5.57 Billion
--
2016-06-30 0.00% AU$0.00
≈ $0.00
AU$7.37 Billion
≈ $5.22 Billion
--
2008-06-30 0.13% AU$4.71 Million
≈ $3.33 Million
AU$3.63 Billion
≈ $2.57 Billion
-0.03pp
2007-06-30 0.16% AU$4.76 Million
≈ $3.37 Million
AU$2.90 Billion
≈ $2.05 Billion
+0.02pp
2006-06-30 0.14% AU$3.36 Million
≈ $2.38 Million
AU$2.35 Billion
≈ $1.66 Billion
+0.15pp
2000-06-30 -0.01% AU$-73.00K
≈ $-51.65K
AU$725.64 Million
≈ $513.44 Million
-0.48pp
1995-06-30 0.47% AU$200.00K
≈ $141.51K
AU$43.01 Million
≈ $30.43 Million
-17.80pp
1994-06-30 18.26% AU$6.25 Million
≈ $4.42 Million
AU$34.22 Million
≈ $24.21 Million
--
pp = percentage points

About Sonic Healthcare Ltd

AU:SHL Australia Diagnostics & Research
Market Cap
$6.94 Billion
AU$9.81 Billion AUD
Market Cap Rank
#2934 Global
#66 in Australia
Share Price
AU$19.84
Change (1 day)
-0.20%
52-Week Range
AU$18.39 - AU$28.93
All Time High
AU$42.28
About

Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal te… Read more